Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, manufacturing and dosing and delivery techniques. The company’s pipeline is focused on severe CNS diseases in need of effective new therapies, including advanced Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS), Huntington’s disease, Friedreich’s ataxia, Alzheimer’s Disease and neuropathic pain.
We are seeking an experienced and highly motivated neurobiologist to contribute to our research team at our facility in Cambridge, Massachusetts. This is an ideal position for an individual with a strong background in in vivo and ex vivo methods, who thrives in a team-oriented, fast-paced, and cross-disciplinary start-up biotech environment. The individual will work in the laboratory and be responsible for experimental execution and data analysis for research studies supporting cutting edge therapeutic programs and platform discovery research in neurodegenerative disease areas. We are looking for a candidate with extensive prior experience in drug discovery in neurodegenerative diseases and with hands-on techniques in rodent in vivo studies, CNS tissue dissection, and downstream analysis (tissue sectioning, immunohistochemistry, RT-qPCR, western blot and ELISA). This position is located in Cambridge, MA and reports to a Senior Scientist.